You can use fundamental analysis to find out if Cipher Pharmaceuticals is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We have analyze and collected data for thirty-three available fundamental indicators for Cipher Pharmaceuticals, which can be compared to its peers. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Cipher Pharmaceuticals to be traded at C$12.14 in 90 days. Key indicators impacting Cipher Pharmaceuticals' financial strength include:
Understanding current and past Cipher Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cipher Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Cipher Pharmaceuticals' assets may result in an increase in income on the income statement.
Cipher Pharmaceuticals competes with Knight Therapeutics, Biosyent, and Aptose Biosciences. Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company was founded in 2000 and is headquartered in Oakville, Canada. CIPHER PHARMACEUTICALS operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs people.
Foreign Associate
Germany
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
You should never invest in Cipher Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Cipher Stock, because this is throwing your money away. Analyzing the key information contained in Cipher Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Cipher Pharmaceuticals Key Financial Ratios
Cipher Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Cipher Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Cipher Pharmaceuticals over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Cipher Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Cipher Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cipher Pharmaceuticals competition to find correlations between indicators driving Cipher Pharmaceuticals's intrinsic value. More Info.
Cipher Pharmaceuticals is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.20 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Cipher Pharmaceuticals is roughly 4.90 . At this time, Cipher Pharmaceuticals' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Cipher Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cipher Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.
Cipher Pharmaceuticals Systematic Risk
Cipher Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cipher Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Cipher Pharmaceuticals correlated with the market. If Beta is less than 0 Cipher Pharmaceuticals generally moves in the opposite direction as compared to the market. If Cipher Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cipher Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cipher Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Cipher Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Cipher Pharmaceuticals Total Assets Over Time
Today, most investors in Cipher Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cipher Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cipher Pharmaceuticals growth as a starting point in their analysis.
Cipher Pharmaceuticals March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cipher Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cipher Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cipher Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Cipher Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cipher Pharmaceuticals's daily price indicators and compare them against related drivers.
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.